Laure Calvet
Overview
Explore the profile of Laure Calvet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lescroart M, Kemp H, Imauven O, Raphalen J, Bagate F, Schmidt J, et al.
J Crit Care
. 2025 Jan;
87:155028.
PMID: 39848115
Purpose: Onco-hematological (OH) patients face significant cardiovascular risks due to malignancy and drug toxicity. Data are limited on the characteristics and outcomes of OH patients with cardiogenic shock (CS) in...
2.
Bouzgarrou R, Farigon N, Morlat L, Bouaziz S, Philipponet C, Laurichesse G, et al.
Sci Rep
. 2024 Nov;
14(1):27389.
PMID: 39521842
To determine the prevalence of functional, respiratory and renal impairments and of post-intensive-care-syndrome (PICS) among patients who had attended a post-ICU multidisciplinary consultation (post-ICU-MC) around 3 months after ICU discharge,...
3.
Mascle O, Dupuis C, Brailova M, Bonnet B, Mirand A, Chauvot de Beauchene R, et al.
PLoS One
. 2024 Nov;
19(11):e0307938.
PMID: 39485788
Introduction: The COVID-19 pandemic has been associated with significant variability in acute kidney injury (AKI) incidence, leading to concerns regarding patient heterogeneity. The study's primary objective was a cluster analysis,...
4.
Calvet L, Lemiale V, Mokart D, Peter S, Peter P, Demoule A, et al.
Ann Intensive Care
. 2024 Jul;
14(1):120.
PMID: 39083132
Background: The accuracy of a diagnostic test depends on its intrinsic characteristics and the disease incidence. This study aims to depict post-test probability of Pneumocystis pneumonia (PJP), according to results...
5.
Malherbe J, Godard P, Lacherade J, Coirier V, Argaud L, Hyvernat H, et al.
Ann Intensive Care
. 2024 Mar;
14(1):44.
PMID: 38548917
Background: Due to aging population and increasing part of immunocompromised patients, a raise in life-threatening organ damage related to VZV can be expected. Two retrospective studies were already conducted on...
6.
Baucher L, Lemiale V, Joseph A, Wallet F, De Chambrun M, Ferre A, et al.
Ann Intensive Care
. 2023 Dec;
13(1):123.
PMID: 38055081
Background: In the last decade, Ibrutinib has become the standard of care in the treatment of several lymphoproliferative diseases such as chronic lymphocytic leukemia (CLL) and several non-Hodgkin lymphoma. Beyond...
7.
Grapin K, De Bauchene R, Bonnet B, Mirand A, Cassagnes L, Calvet L, et al.
Crit Care Med
. 2023 Oct;
52(2):e38-e46.
PMID: 37889095
Background: Inconsistent results from COVID-19 studies raise the issue of patient heterogeneity. Objective: The objective of this study was to identify homogeneous subgroups of patients (clusters) using baseline characteristics including...
8.
Zafrani L, Canet E, Walter-Petrich A, Joly-Laffargue B, Veyradier A, Faguer S, et al.
Intensive Care Med
. 2023 Oct;
49(11):1293-1304.
PMID: 37867165
Purpose: Studies have suggested benefits from magnesium sulphate in thrombotic thrombocytopenic purpura (TTP). We aimed to measure the effects of magnesium sulphate supplementation on TTP recovery. Methods: In this multicenter,...
9.
Giacobbe D, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, et al.
Crit Care
. 2023 Aug;
27(1):323.
PMID: 37620828
Background: Pneumocystis jirovecii pneumonia (PJP) is an opportunistic, life-threatening disease commonly affecting immunocompromised patients. The distribution of predisposing diseases or conditions in critically ill patients admitted to intensive care unit...
10.
Ruault A, Philipponnet C, Sapin V, Evrard B, Bouzgarrou R, Calvet L, et al.
Biomedicines
. 2023 May;
11(4).
PMID: 37189619
Background: The clinical significance of early-onset acute kidney injury (EO-AKI) and recovery in severe COVID-19 intensive care unit (ICU) patients is poorly documented. Objective: The aim of the study was...